Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: RJ2002
5
Aug 27, 2009 09:21PM

Aug 27, 2009 10:58PM

Other than for breaches of the Agreement, I believe that this is pertinent:

5.1 This Commercialization Agreement shall continue for the useful life of the MSD Patents, which shall be deemed to be the greater of the period of time during which any of the MSD Patents is either (i) susceptible to legal protection, or (ii) reasonably perceived to have commercial value.

5.2 In the event that facts or events are discovered or occur which materially reduce TPL's evaluation of the useful life or commercial value of the MSD Patents, or the viability of the Project, TPL may reduce the term of this Commercialization Agreement accordingly by providing P-Newco with ninety (90) days written notice, provided that TPL shall not reduce the term of this Commercialization Agreement to less than six (6) months.

5.3 After the expiration of the term provided for above, neither party shall have any further obligation hereunder other than the administration of all outstanding transactions as under Article VI below, and the obligations of confidentiality undertaken by the parties

http://www.pinksheets.com/edgar/GetFilingHtml?FilingID=3740542

.

.

Be well

2
Aug 28, 2009 05:52AM
1
Aug 28, 2009 08:54AM

Aug 28, 2009 09:25AM
Share
New Message
Please login to post a reply